CNP - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 45/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

5/7 Elevated

5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.5x).

Beta (Market Relation)

0.46x

Defensive

Volatility (5Y p.a.)

19.6% p.a.

5-Year Horizon

Max Drawdown (5Y)

-22.8%

5-Year Horizon

Sharpe Ratio

0.31

Return / Risk

Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	-2.9%
3 Years	18.4%	-18.7%	0.52	+12.1%
5 Years	19.6%	-22.8%	0.31	+8.5%
10 Years	25.9%	-61.5%	0.12	+5.6%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 210%.

Historical Stress Test: Maximum peak-to-trough drawdown of -61.5% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)

Overall Governance Risk

7 ISS Score: 7 / 10

Audit Risk

8 ISS Score: 8 / 10

Board Risk

5 ISS Score: 5 / 10

Short Ratio

7.87